Your Journey to Sustainable Weight Loss Starts Here At Arogya Med Care, we understand that every individual's weight loss journey is unique
Because its baked in one dish, you can easily enjoy a square without committing to a big meal
Skin Whitening: Glutathione reduces melanin production, leading to a lighter and more even skin tone
Mar 19, 2026, 12:04 ET Average weight loss of ~21% at 72 weeks in adults with obesity if all patients stayed on treatment * with Wegovy HD (~19% regardless of whether patients stayed on treatment ** ) in the STEP UP trial 1 In the STEP UP trial, about one in three trial participants taking Wegovy HD achieved 25% weight loss or higher 1 This approval for Wegovy further expands its already robust label inclusive of multiple formulations, including Wegovy pill, and indications not available with other GLP-1 weight loss medicines PLAINSBORO, N.J., March 19, 2026 /PRNewswire/ -- Novo Nordisk today announced US Food and Drug Administration (FDA) approval of a new higher dose of Wegovy , Wegovy HD (semaglutide) injection 7.2 mg, which demonstrated substantial weight loss in adults with obesity in the STEP UP trial
doi: 10.1111/J.1582-4934.2006.TB00407.X 169 VistoliGde MaddisDCipakAZarkovicNCariniMAldiniG